Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420561 · ClinicalTrials.gov registry record · NA
Motivational Interviewing to Reduce Substance Use Among Depression Patients
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 307
- Enrollment target
NCT02420561: Completed NA study, sponsored by University of California, San Francisco.
NCT02420561 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 307 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02420561, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 307 participants
- Enrollment target
Study Summary
The study aims to evaluate the effectiveness of an intervention to reduce alcohol and drug use and depression symptoms, improve functional status and promote appropriate health services utilization, in a sample of 300 adults seeking treatment for depression who also report hazardous drinking or drug use with depression.
Primary Outcome
Self-reported number of days of hazardous drinking (3+ drinks per day for women / 4+ drinks per day for men) in the prior 30 days.
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Control (brochure)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT02420561 record still lists
NCT02420561 is an interventional study that assigns participants to a tested intervention. The registered 307 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing is the first listed.
NCT02420561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02420561 about?
NCT02420561 is a clinical study titled "Motivational Interviewing to Reduce Substance Use Among Depression Patients". The study aims to evaluate the effectiveness of an intervention to reduce alcohol and drug use and depression symptoms, improve functional status and promote appropriate health services utilization, in a sample of 300 adults seeking treatment for depression who also report hazardous drinking or drug...
What is the current status of trial NCT02420561?
This trial is currently completed. It is a NA study. The enrollment target is 307 participants. The study started on 2010-10. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02420561?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Control (brochure) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02420561?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02420561's enrollment target sits among peer trials
307 324th of 2000 higher than 1,677 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05433142 · 307 participants · Phase 1
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia